New combo test aims to spot ventilator pneumonia faster
NCT ID NCT06181669
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 173 adults on ventilators to see if combining advanced germ-detection tests with a patient's immune response can improve diagnosis of ventilator-associated pneumonia. Researchers compared several molecular tests and host-response markers to standard clinical methods. The goal is to pave the way for future studies that could lead to faster, more accurate treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA, BACTERIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Corewell (William Beaumont)
Royal Oak, Michigan, 48073, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Speedier lab test could curb superbug threat in ICU pneumonia
- Does the setting of care affect whether kids finish their antibiotics?
- Inhaled antibiotics aim to beat pneumonia in ECMO patients
- Human milk mouth care may shield preemies from lung infections
- Could a 'robotic cough' stop deadly pneumonia in ICU patients?